Authors
Loading...
Preclinical study demonstrates that cytoplasmic METTL3 drives exocytosis and invasion in breast cancer models, indicating an enzymatic-independent role in tumor progression.
Esteva-Socias et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: